Literature DB >> 33661192

FDG PET Findings Post-COVID Vaccinations: Signs of the Times?

Saba Moghimi1, Don Wilson, Patrick Martineau.   

Abstract

ABSTRACT: Vaccinations can cause hypermetabolic axillary lymphadenopathy on FDG PET. We present the case of a 71-year-old man who underwent FDG PET/CT for melanoma staging 6 days following a COVID (coronavirus disease) vaccination. Imaging showed a prominent intramuscular mass at the vaccination site, in addition to extensive axillary lymphadenopathy. The mass was compatible with a hematoma at the vaccination site, and the lymphadenopathy was most likely reactive. This case demonstrates unconventional findings in response to a routine vaccination event-findings that, in light of current world events, are likely to be routinely encountered on PET imaging and that should be recognized reactive rather malignant.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33661192     DOI: 10.1097/RLU.0000000000003636

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  8 in total

1.  Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy.

Authors:  Dan Cohen; Shir Hazut Krauthammer; Yael C Cohen; Chava Perry; Irit Avivi; Yair Herishanu; Einat Even-Sapir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-08       Impact factor: 9.236

2.  PET findings after COVID-19 vaccination: "Keep Calm and Carry On".

Authors:  Barbara Muoio; Luigia Elzi; Giorgio Treglia; Marco Cuzzocrea
Journal:  Clin Transl Imaging       Date:  2021-05-13

Review 3.  Lymphadenopathy Following COVID-19 Vaccination: Imaging Findings Review.

Authors:  Pedram Keshavarz; Fereshteh Yazdanpanah; Faranak Rafiee; Malkhaz Mizandari
Journal:  Acad Radiol       Date:  2021-05-01       Impact factor: 3.173

Review 4.  COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature.

Authors:  Jihe Lim; Seun Ah Lee; Eun Kyung Khil; Sun-Ju Byeon; Hee Joon Kang; Jung-Ah Choi
Journal:  Semin Oncol       Date:  2021-10-26       Impact factor: 4.929

5.  Subdiaphragmatic Lymph Nodes Uptake on 18F-FDG PET/CT After COVID-19 Vaccination in the Thigh.

Authors:  Elske Quak; Adeline Morel; Julie Faudemer; Christelle Levy; Renaud Ciappuccini
Journal:  Clin Nucl Med       Date:  2022-03-01       Impact factor: 7.794

6.  Lymphadenopathy subsequent to Covishield (ChAdOx1 nCoV-19) Corona virus vaccine: ultrasound findings and clinical implications.

Authors:  Soumya Swaroop Sahoo; Navdeep Kaur; Amandeep Kaur; Shivane Garg
Journal:  Ther Adv Vaccines Immunother       Date:  2022-09-17

7.  COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine.

Authors:  Muheon Shin; Chae Young Hyun; Yoon Ho Choi; Joon Young Choi; Kyung-Han Lee; Young Seok Cho
Journal:  Clin Nucl Med       Date:  2021-10-01       Impact factor: 10.782

Review 8.  Lymphadenopathy post-COVID-19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic review.

Authors:  Khalifa Bshesh; Wafa Khan; Ahamed Lazim Vattoth; Emmad Janjua; Areej Nauman; Muna Almasri; Ateeque Mohamed Ali; Vinutha Ramadorai; Beshr Mushannen; Mai AlSubaie; Ibrahim Mohammed; Mais Hammoud; Pradipta Paul; Haya Alkaabi; Aliyaa Haji; Sa'ad Laws; Dalia Zakaria
Journal:  J Med Virol       Date:  2022-02-07       Impact factor: 20.693

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.